Louisiana State Employees Retirement System purchased a new position in shares of Envista Holdings Corporation (NYSE:NVST – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 47,500 shares of the company’s stock, valued at approximately $1,205,000.
A number of other hedge funds have also bought and sold shares of NVST. Royal Bank of Canada raised its stake in Envista by 26.6% during the first quarter. Royal Bank of Canada now owns 23,240 shares of the company’s stock valued at $401,000 after buying an additional 4,885 shares in the last quarter. Millennium Management LLC increased its holdings in shares of Envista by 218.6% in the 1st quarter. Millennium Management LLC now owns 383,966 shares of the company’s stock valued at $6,627,000 after acquiring an additional 263,442 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of Envista by 39.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company’s stock valued at $10,859,000 after acquiring an additional 177,630 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Envista by 15.5% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company’s stock valued at $9,821,000 after acquiring an additional 76,246 shares in the last quarter. Finally, Prudential Financial Inc. raised its position in shares of Envista by 22.1% during the 2nd quarter. Prudential Financial Inc. now owns 18,785 shares of the company’s stock valued at $367,000 after acquiring an additional 3,395 shares in the last quarter.
Analyst Ratings Changes
Several equities analysts recently issued reports on the company. Robert W. Baird raised their price objective on Envista from $30.00 to $31.00 and gave the stock an “outperform” rating in a research note on Thursday, May 7th. Zacks Research cut shares of Envista from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. Citigroup initiated coverage on shares of Envista in a research report on Wednesday, April 15th. They issued a “neutral” rating and a $29.00 price target on the stock. Barclays decreased their price target on shares of Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a report on Thursday, June 11th. Finally, Wall Street Zen downgraded shares of Envista from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Six equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $28.67.
Envista Stock Performance
Envista stock opened at $27.59 on Friday. The firm’s 50 day simple moving average is $24.86 and its 200-day simple moving average is $25.27. The company has a market cap of $4.49 billion, a P/E ratio of 67.28, a price-to-earnings-growth ratio of 1.57 and a beta of 0.86. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.44 and a quick ratio of 2.06. Envista Holdings Corporation has a fifty-two week low of $18.77 and a fifty-two week high of $30.42.
Envista (NYSE:NVST – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.31 by $0.05. The business had revenue of $705.50 million during the quarter, compared to the consensus estimate of $680.03 million. Envista had a net margin of 2.41% and a return on equity of 7.11%. The firm’s quarterly revenue was up 14.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, equities research analysts predict that Envista Holdings Corporation will post 1.42 EPS for the current year.
Envista Company Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Further Reading
- Five stocks we like better than Envista
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
